ReShape Lifesciences Inc. (RSLS)
USD 0.38
(-15.62%)
USD 0.38
(-15.62%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 20.18 Million USD | -40.42% |
| 2022 | 33.88 Million USD | -6.14% |
| 2021 | 36.09 Million USD | 92.84% |
| 2020 | 18.71 Million USD | -25.69% |
| 2019 | 25.19 Million USD | 0.83% |
| 2018 | 24.98 Million USD | -21.33% |
| 2017 | 31.75 Million USD | 37.18% |
| 2016 | 23.15 Million USD | -17.42% |
| 2015 | 28.03 Million USD | 9.54% |
| 2014 | 25.59 Million USD | 3.47% |
| 2013 | 24.73 Million USD | 9.3% |
| 2012 | 22.62 Million USD | -10.4% |
| 2011 | 25.25 Million USD | 56.13% |
| 2010 | 16.17 Million USD | -33.19% |
| 2009 | 24.21 Million USD | -33.25% |
| 2008 | 36.27 Million USD | 29.42% |
| 2007 | 28.02 Million USD | 54.65% |
| 2006 | 18.12 Million USD | 62.49% |
| 2005 | 11.15 Million USD | 423.37% |
| 2004 | -3.44 Million USD | -81.42% |
| 2003 | -1.9 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.37 Million USD | -9.69% |
| 2024 Q2 | 3.18 Million USD | -5.54% |
| 2023 Q3 | 4.39 Million USD | -15.61% |
| 2023 Q2 | 5.2 Million USD | -24.1% |
| 2023 Q1 | 6.85 Million USD | 8.71% |
| 2023 FY | 20.18 Million USD | -40.42% |
| 2023 Q4 | 3.73 Million USD | -14.89% |
| 2022 Q1 | 9.61 Million USD | 12.08% |
| 2022 Q2 | 10.74 Million USD | 11.73% |
| 2022 FY | 33.88 Million USD | -6.14% |
| 2022 Q4 | 6.3 Million USD | -9.55% |
| 2022 Q3 | 6.97 Million USD | -35.12% |
| 2021 Q2 | 5.85 Million USD | 28.94% |
| 2021 Q1 | 4.54 Million USD | -6.29% |
| 2021 Q3 | 17.11 Million USD | 192.38% |
| 2021 Q4 | 8.58 Million USD | -49.87% |
| 2021 FY | 36.09 Million USD | 92.84% |
| 2020 Q1 | 5.58 Million USD | 17.75% |
| 2020 FY | 18.71 Million USD | -25.69% |
| 2020 Q3 | 4.45 Million USD | 16.11% |
| 2020 Q4 | 4.84 Million USD | 8.83% |
| 2020 Q2 | 3.83 Million USD | -31.33% |
| 2019 Q3 | 6.22 Million USD | -19.76% |
| 2019 Q2 | 7.75 Million USD | 19.69% |
| 2019 FY | 25.19 Million USD | 0.83% |
| 2019 Q4 | 4.74 Million USD | -23.75% |
| 2019 Q1 | 6.47 Million USD | 243.0% |
| 2018 Q3 | 7.63 Million USD | -16.61% |
| 2018 FY | 24.98 Million USD | -21.33% |
| 2018 Q1 | 12.73 Million USD | 5.35% |
| 2018 Q2 | 9.14 Million USD | -28.15% |
| 2018 Q4 | -4.52 Million USD | -159.36% |
| 2017 Q1 | 7.05 Million USD | 68.62% |
| 2017 Q3 | 5.7 Million USD | -17.47% |
| 2017 Q2 | 6.91 Million USD | -1.99% |
| 2017 Q4 | 12.08 Million USD | 111.86% |
| 2017 FY | 31.75 Million USD | 37.18% |
| 2016 Q4 | 4.18 Million USD | -9.36% |
| 2016 FY | 23.15 Million USD | -17.42% |
| 2016 Q2 | 6.77 Million USD | -10.49% |
| 2016 Q1 | 7.57 Million USD | -0.74% |
| 2016 Q3 | 4.61 Million USD | -31.92% |
| 2015 Q1 | 6.96 Million USD | 14.41% |
| 2015 Q4 | 7.63 Million USD | 26.09% |
| 2015 Q3 | 6.05 Million USD | -18.11% |
| 2015 Q2 | 7.38 Million USD | 6.1% |
| 2015 FY | 28.03 Million USD | 9.54% |
| 2014 Q1 | 6.55 Million USD | 2.89% |
| 2014 Q2 | 7.35 Million USD | 12.14% |
| 2014 Q4 | 6.08 Million USD | 8.81% |
| 2014 Q3 | 5.59 Million USD | -23.94% |
| 2014 FY | 25.59 Million USD | 3.47% |
| 2013 Q1 | 6.31 Million USD | -6.54% |
| 2013 Q2 | 6.07 Million USD | -3.92% |
| 2013 Q3 | 5.97 Million USD | -1.66% |
| 2013 Q4 | 6.37 Million USD | 6.77% |
| 2013 FY | 24.73 Million USD | 9.3% |
| 2012 Q1 | 5.52 Million USD | -29.95% |
| 2012 Q3 | 5.57 Million USD | 16.79% |
| 2012 Q4 | 6.76 Million USD | 21.32% |
| 2012 Q2 | 4.77 Million USD | -13.61% |
| 2012 FY | 22.62 Million USD | -10.4% |
| 2011 Q1 | 4.85 Million USD | 34.18% |
| 2011 Q2 | 5.38 Million USD | 10.79% |
| 2011 Q3 | 7.13 Million USD | 32.56% |
| 2011 Q4 | 7.88 Million USD | 10.55% |
| 2011 FY | 25.25 Million USD | 56.13% |
| 2010 Q3 | 4.09 Million USD | -0.5% |
| 2010 FY | 16.17 Million USD | -33.19% |
| 2010 Q1 | 4.34 Million USD | -13.29% |
| 2010 Q2 | 4.11 Million USD | -5.39% |
| 2010 Q4 | 3.61 Million USD | -11.59% |
| 2009 FY | 24.21 Million USD | -33.25% |
| 2009 Q4 | 5.01 Million USD | -30.98% |
| 2009 Q1 | 5.69 Million USD | -11.91% |
| 2009 Q2 | 6.23 Million USD | 9.43% |
| 2009 Q3 | 7.26 Million USD | 16.55% |
| 2008 Q4 | 6.46 Million USD | -35.72% |
| 2008 Q1 | 8.51 Million USD | -1.78% |
| 2008 Q2 | 11.22 Million USD | 31.83% |
| 2008 Q3 | 10.06 Million USD | -10.37% |
| 2008 FY | 36.27 Million USD | 29.42% |
| 2007 Q1 | -6.6 Million USD | -26.51% |
| 2007 Q3 | 6.45 Million USD | 197.62% |
| 2007 FY | 28.02 Million USD | 54.65% |
| 2007 Q4 | 8.66 Million USD | 34.36% |
| 2007 Q2 | -6.6 Million USD | 0.0% |
| 2006 FY | 18.12 Million USD | 62.49% |
| 2006 Q2 | -4.15 Million USD | 0.0% |
| 2006 Q4 | -5.22 Million USD | -25.74% |
| 2006 Q3 | -4.15 Million USD | 0.0% |
| 2006 Q1 | -4.15 Million USD | -48.2% |
| 2005 Q2 | -2.8 Million USD | 0.0% |
| 2005 FY | 11.15 Million USD | 423.37% |
| 2005 Q1 | -2.8 Million USD | 0.0% |
| 2005 Q4 | -2.8 Million USD | 0.0% |
| 2005 Q3 | -2.8 Million USD | 0.0% |
| 2004 FY | -3.44 Million USD | -81.42% |
| 2003 FY | -1.9 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -79.856% |
| Cerus Corporation | 143.15 Million USD | 85.899% |
| OrthoPediatrics Corp. | 137.01 Million USD | 85.267% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -77.689% |
| Talis Biomedical Corporation | 67.18 Million USD | 69.954% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 19.077% |
| Inogen, Inc. | 236.08 Million USD | 91.449% |
| Spectral AI, Inc. | 20.86 Million USD | 3.245% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 63.95% |
| CVRx, Inc. | 76.14 Million USD | 73.488% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -472.195% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -61.638% |
| Orthofix Medical Inc. | 667.42 Million USD | 96.975% |
| Venus Concept Inc. | 80.47 Million USD | 74.916% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 64.32% |
| Bioventus Inc. | 409.91 Million USD | 95.075% |
| BrainsWay Ltd. | 28.01 Million USD | 27.95% |
| Envoy Medical, Inc. | 17.89 Million USD | -12.789% |
| electroCore, Inc. | 32.03 Million USD | 36.977% |
| IceCure Medical Ltd | 16.87 Million USD | -19.62% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 52.425% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -14.484% |
| MaxCyte, Inc. | 84.84 Million USD | 76.207% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -62.644% |
| Nexalin Technology, Inc. | 5.78 Million USD | -249.174% |
| PAVmed Inc | 64.82 Million USD | 68.86% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 60.478% |
| RxSight, Inc. | 103.85 Million USD | 80.561% |
| Sight Sciences, Inc. | 126.44 Million USD | 84.035% |
| SI-BONE, Inc. | 156.35 Million USD | 87.089% |
| TELA Bio, Inc. | 84.18 Million USD | 76.021% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 71.184% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 90.074% |
| LivaNova PLC | 843.54 Million USD | 97.607% |
| 908 Devices Inc. | 68.08 Million USD | 70.348% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 95.826% |
| Nemaura Medical Inc. | 7.13 Million USD | -182.778% |
| NeuroPace, Inc. | 75.29 Million USD | 73.19% |
| LENSAR, Inc. | 33.33 Million USD | 39.444% |
| Apyx Medical Corporation | 51.01 Million USD | 60.432% |
| Cutera, Inc. | 197.72 Million USD | 89.79% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 18.538% |
| BioSig Technologies, Inc. | 28.53 Million USD | 29.243% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 89.457% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 44.018% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 97.586% |
| Axonics, Inc. | 270.2 Million USD | 92.529% |
| Outset Medical, Inc. | 198.77 Million USD | 89.844% |
| IRIDEX Corporation | 31.81 Million USD | 36.547% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 88.799% |
| IRadimed Corporation | 30.12 Million USD | 32.984% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -136.603% |
| INVO Bioscience, Inc. | 7.85 Million USD | -157.051% |
| Telesis Bio, Inc. | 63.48 Million USD | 68.204% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 79.496% |
| Varex Imaging Corporation | 224.8 Million USD | 91.02% |
| Quipt Home Medical Corp. | 148.66 Million USD | 86.421% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -72.2% |
| Pulmonx Corporation | 112.68 Million USD | 82.086% |
| Dynatronics Corporation | 9.9 Million USD | -103.744% |
| Modular Medical, Inc. | 17.52 Million USD | -15.163% |
| Semler Scientific, Inc. | 38.94 Million USD | 48.164% |
| InMode Ltd. | 215.68 Million USD | 90.64% |
| Bruker Corporation | 1.07 Billion USD | 98.125% |
| Cytosorbents Corporation | 48.33 Million USD | 58.237% |
| DexCom, Inc. | 1.69 Billion USD | 98.806% |
| Align Technology, Inc. | 2.07 Billion USD | 99.028% |
| Viveve Medical, Inc. | 22.17 Million USD | 8.957% |
| ZimVie Inc. | 275.12 Million USD | 92.663% |
| Movano Inc. | 29.69 Million USD | 32.007% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 85.294% |
| Nexalin Technology, Inc. | 5.78 Million USD | -249.174% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -472.195% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 96.641% |
| Profound Medical Corp. | 33.6 Million USD | 39.925% |
| Insulet Corporation | 939.9 Million USD | 97.852% |
| enVVeno Medical Corporation | 25.23 Million USD | 20.013% |
| Surmodics, Inc. | 98.69 Million USD | 79.546% |
| iCAD, Inc. | 22.22 Million USD | 9.17% |
| Nuwellis, Inc. | 22.61 Million USD | 10.728% |
| Biotricity, Inc. | 17.18 Million USD | -17.472% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 95.473% |
| Aethlon Medical, Inc. | 12.27 Million USD | -64.423% |
| InspireMD, Inc. | 22.95 Million USD | 12.039% |
| PAVmed Inc. | 64.82 Million USD | 68.86% |
| BIOLASE, Inc. | 34.66 Million USD | 41.759% |
| Beyond Air, Inc. | 61.7 Million USD | 67.282% |
| FONAR Corporation | 28.6 Million USD | 29.428% |
| AxoGen, Inc. | 149.33 Million USD | 86.482% |
| Vivani Medical, Inc. | 26.96 Million USD | 25.136% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 88.601% |
| Inari Medical, Inc. | 448.59 Million USD | 95.5% |
| UFP Technologies, Inc. | 58.08 Million USD | 65.248% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -309.672% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -219.501% |
| Tenon Medical, Inc. | 16.96 Million USD | -18.971% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -173.056% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 54.227% |
| AdaptHealth Corp. | 1.07 Billion USD | 98.127% |
| Sintx Technologies, Inc. | 15.2 Million USD | -32.8% |
| NanoVibronix, Inc. | 4.97 Million USD | -305.932% |
| Quanterix Corporation | 118.1 Million USD | 82.907% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -72.2% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -39.78% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 94.859% |
| TransMedics Group, Inc. | 182.82 Million USD | 88.958% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 28.071% |
| NeuroMetrix, Inc. | 11.09 Million USD | -81.882% |
| Hyperfine, Inc. | 52.87 Million USD | 61.819% |
| Establishment Labs Holdings Inc. | 172 Million USD | 88.264% |
| Biomerica, Inc. | 6.97 Million USD | -189.295% |
| Bone Biologics Corporation | 9.42 Million USD | -114.111% |
| AVITA Medical, Inc. | 80.77 Million USD | 75.01% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -95.777% |
| Silk Road Medical, Inc | 186.35 Million USD | 89.168% |